Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Antimicrobial Agents and Chemotherapy|April 29, 2026
Pretomanid vs delamanid in a bedaquiline-linezolid regimen: efficacy in a high-burden tuberculosis mouse modelJason E Cummings, Lisa K Woolhiser, Vincent Guglielmi, et al.
Frontiers in Pharmacology|October 1, 2025
Evaluating the efficacy of HRZE-based regimens in a high-burden murine model: a back-translational assessment of rifamycins and moxifloxacin substitutions in tuberculosis treatmentJason E Cummings, Lisa K Woolhiser, Vincent Guglielmi, et al.
Frontiers in Pharmacology|December 4, 2025
Correction: Evaluating the efficacy of HRZE-based regimens in a high-burden murine model: a back-translational assessment of rifamycins and moxifloxacin substitutions in tuberculosis treatmentJason E Cummings, Lisa K Woolhiser, Vincent Guglielmi, et al.
The Journal of Biological Chemistry|January 2, 2004
Structure-activity determinants in paneth cell alpha-defensins: loss-of-function in mouse cryptdin-4 by charge-reversal at arginine residue positionsHiroki Tanabe, Xiaoqing Qu, Colby S Weeks, et al.
ACS Infectious Diseases|January 10, 2025
Anti-Mycobacterial Activity of Bacterial Topoisomerase Inhibitors with Dioxygenated LinkersMark J Mitton-Fry, Jason E Cummings, Yanran Lu, et al.
Biochemistry|February 23, 2017
Rationalizing the Binding Kinetics for the Inhibition of the Burkholderia pseudomallei FabI1 Enoyl-ACP ReductaseCarla Neckles, Sandra Eltschkner, Jason E Cummings, et al.
Antimicrobial Agents and Chemotherapy|June 18, 2024
Rapid in vitro activity of telavancin against Bacillus anthracis and in vivo protection against inhalation anthrax infection in the rabbit modelWilliam S Lawrence, Jennifer E Peel, Richard A Slayden, et al.
Microbiology Spectrum|March 27, 2024
Targeting intracellular nontuberculous mycobacteria and M. tuberculosis with a bactericidal enzymatic cocktailHelen P Bartlett, Clinton C Dawson, Cody M Glickman, et al.
Antimicrobial Agents and Chemotherapy|January 1, 2014
Substituted diphenyl ethers as a novel chemotherapeutic platform against Burkholderia pseudomalleiJason E Cummings, Adam J Beaupre, Susan E Knudson, et al.
Frontiers in Immunology|March 7, 2022
A Novel Glucocorticoid and Androgen Receptor Modulator Reduces Viral Entry and Innate Immune Inflammatory Responses in the Syrian Hamster Model of SARS-CoV-2 InfectionSavannah M Rocha, Anna C Fagre, Amanda S Latham, et al.
Pageof 4